Gilead set for high-stakes PTAB clash with the US government over HIV patents

Gilead set for high-stakes PTAB clash with the US government over HIV patents

The company’s attack on rights held by the Department of Health and Human Services has significant commercial, political and even strategic IP implications

Unlock unlimited access to all IAM content